Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Pleurectomy/Decortication Plus Systemic Therapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)

NCT04158141 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT04158141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Pleurectomy/Decortication Plus Systemic Therapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Terminated
Start date
January 29, 2020
Completion date
November 20, 2023
Enrollment
16 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

pleural biphasic mesothelioma, pleural epithelioid mesothelioma, stage i pleural malignant mesothelioma ajcc v8, stage ia pleural malignant mesothelioma ajcc v8, stage ib pleural malignant mesothelioma ajcc v8, stage ii pleural malignant mesothelioma ajcc v8, stage iiia pleural malignant mesothelioma ajcc v8